Paclitaxel ceribate

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePaclitaxel ceribate
Drug Alias NameProtaxelBP-179
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInterpharma Praha As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInterpharma Praha As
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A